SA44WHAT CPGS CAN TELL: AN APPROACH TO THE METHYLATION PATTERN OF BDNF PROMOTER IV IN MAJOR DEPRESSION DISORDER AND ITS RELATION TO STRESS

dc.contributor.authorMaría Marcela Velásquez Toledo
dc.contributor.authorYvonne Gómez Maquet
dc.contributor.authorEugenio Ferro
dc.contributor.authorÁlvaro Arenas
dc.contributor.authorCatalina González Uribe
dc.contributor.authorIleana Manzanilla
dc.contributor.authorClaudia Lattig
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T18:02:13Z
dc.date.available2026-03-22T18:02:13Z
dc.date.issued2019
dc.identifier.doi10.1016/j.euroneuro.2018.08.266
dc.identifier.urihttps://doi.org/10.1016/j.euroneuro.2018.08.266
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/67728
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.sourceUniversidad de Los Andes
dc.subjectHaploinsufficiency
dc.subjectFrontotemporal lobar degeneration
dc.subjectPhenotype
dc.subjectFrontotemporal dementia
dc.subjectPsychology
dc.subjectNeuroscience
dc.subjectGenetics
dc.subjectBioinformatics
dc.subjectMedicine
dc.subjectBiology
dc.titleSA44WHAT CPGS CAN TELL: AN APPROACH TO THE METHYLATION PATTERN OF BDNF PROMOTER IV IN MAJOR DEPRESSION DISORDER AND ITS RELATION TO STRESS
dc.typearticle

Files